Introducere
Această pagină oferă o analiză cuprinzătoare a istoricului cunoscut al tranzacțiilor privilegiate a Ernest Mario. Insiders sunt ofițeri, directori sau investitori importanți într-o companie. Este ilegal ca persoanele din interior să facă tranzacții în companiile lor pe baza unor informații specifice, nepublice. Acest lucru nu înseamnă că este ilegal pentru ei să facă tranzacții în propriile companii. Cu toate acestea, ei trebuie să raporteze toate tranzacțiile către SEC printr-un Formular 4. În ciuda acestor restricții, cercetările academice sugerează că persoanele din interior - în general - tind să depășească piața în propriile companii.
Rentabilitatea medie comercială
Rentabilitatea medie a comerțului este randamentul mediu al tuturor achizițiilor de pe piața deschisă efectuate de persoane din interior în ultimii trei ani. Pentru a calcula acest lucru, examinăm fiecare achiziție neplanificată pe piață deschisă făcută de către insider, excluzând toate tranzacțiile care au fost marcate ca parte a unui plan de tranzacționare 10b5-1. Apoi calculăm performanța medie a acelor tranzacții pe 3, 6 și 12 luni, făcând o medie a fiecărei durate pentru a genera o valoare finală a performanței pentru fiecare tranzacție. În cele din urmă, facem o medie a tuturor valorilor de performanță pentru a calcula o valoare de performanță pentru persoana din interior. Această listă include doar persoane din interior care au efectuat cel puțin trei tranzacții în ultimii doi ani.
Dacă profitabilitatea acestei tranzacții este „N/A”, atunci acesta fie nu a făcut nicio achiziție pe piața deschisă în ultimii trei ani, fie tranzacțiile pe care le-au făcut sunt prea recente pentru a calcula o măsură de performanță fiabilă.
Frecvența actualizării: zilnic
Consultați lista celor mai profitabili comercianți din interior.
Companii cu poziții din interior raportate
Înregistrările SEC indică faptul că Ernest Mario a raportat participații sau tranzacții în următoarele companii:
| Securitate | Titlu | Ultimele participații raportate |
|---|---|---|
| US:SLNO / Soleno Therapeutics, Inc. | Director | 193.066 |
| US:EYEN / Eyenovia, Inc. | Director | 9.653 |
| Director | 49.000 | |
| US:CELG / Celgene Corp. | Director | 0 |
| US:TNXP / Tonix Pharmaceuticals Holding Corp. | Director | 50.000 |
| US:CMRX / Chimerix, Inc. | Director | 108.167 |
| US:BSX / Boston Scientific Corporation | Director | 86.032 |
| US:XNPT / XenoPort, Inc. | Director | 0 |
| US:928551AA8 / VIVUS, Inc. Bond | Director | 81.125 |
| US:MAXY / Maxygen Inc | Director | 62.964 |
Cum se interpretează diagramele
Următoarele diagrame arată performanța acțiunilor de valori mobiliare ulterioare fiecărei tranzacții neplanificate pe piață deschisă efectuată de Ernest Mario. Comerțurile neplanificate sunt tranzacții care nu au fost efectuate ca parte a unui plan de tranzacționare 10b5-1. Performanța acțiunilor este reprezentată ca variație procentuală cumulată a prețului acțiunilor. De exemplu, dacă o tranzacție privilegiată a fost efectuată la 1 ianuarie 2019, graficul va afișa modificarea procentuală zilnică a titlului până în prezent. Dacă prețul acțiunilor ar merge de la 10 USD la 15 USD în acest timp, modificarea procentuală cumulativă a prețului acțiunilor ar fi de 50%. O modificare a prețului de la 10 USD la 20 USD ar fi 100%, iar o modificare a prețului de la 10 USD la 5 USD ar fi -50%.
În cele din urmă, încercăm să determinăm cât de strâns se corelează tranzacțiile insider-ului cu randamentele în exces (pozitive sau negative) ale prețului acțiunilor, pentru a vedea dacă insider-ul își programează tranzacțiile pentru a profita de informațiile privilegiate. Luați în considerare situația în care un insider făcea asta. În această situație, ne-am aștepta fie la (a) randamente pozitive după achiziții, fie (b) la profituri negative după vânzare. În cazul punctului (a), graficul CUMPĂRĂRI ar arăta o serie de curbe în pantă ascendentă, indicând randamente pozitive după fiecare tranzacție de cumpărare. În cazul (b), graficul VÂNZARE ar arăta o serie de curbe înclinate în jos, indicând randamente negative după fiecare tranzacție de vânzare.
Cu toate acestea, acest lucru în sine nu este suficient pentru a trage concluzii. Dacă, de exemplu, prețul acțiunilor companiei a fost într-o creștere neciclică de-a lungul multor ani, atunci ne-am aștepta ca toate parcelele post-cumpărare să fie în pantă ascendentă. De asemenea, scăderile non-ciclice de-a lungul multor ani ar avea ca rezultat o pantă descendentă post-tranzacționare. Niciunul dintre aceste grafice nu ar sugera activitate de tranzacționare a informațiilor privilegiate.
Cel mai puternic indicator ar fi o situație în care prețul acțiunilor a fost extrem de ciclic, și au existat atât semnale pozitive în graficul CUMPĂRARE, cât și grafice negative pe graficul VÂNZARE. Această situație ar sugera foarte mult un insider care a programat tranzacțiile în avantajul lor financiar.
Achiziții din interior HYPD / Hyperion DeFi, Inc. - Analiza profitului pe termen scurt
În această secțiune, analizăm profitabilitatea fiecărei achiziții neplanificate, pe piață deschisă, efectuată în HYPD / Hyperion DeFi, Inc.. Această analiză ajută la înțelegerea dacă persoana din interior generează în mod constant profituri anormale și merită urmărită. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .
Următorul tabel prezintă cele mai recente achiziții pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.
Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.
Vânzări din interior HYPD / Hyperion DeFi, Inc. - Analiza pierderilor pe termen scurt
În această secțiune, analizăm evitarea pierderilor pe termen scurt a fiecărei vânzări neplanificate, pe piață deschisă, efectuată în HYPD / Hyperion DeFi, Inc.. Un model consistent de evitare a pierderilor poate sugera că viitoarele tranzacții de vânzare pot prezice scăderi ale prețului. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .
Următorul tabel arată cele mai recente vânzări pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.
| Data tranzacției | Ticker | Insider | Raportat Acțiuni |
Raportat Preț |
Ajustat Acțiuni |
Ajustat Preț |
Baza costurilor | Zile pentru Min |
Pret la Min |
Pierdere maximă Evitat ($) |
Pierdere maximă Evitat (%) |
|---|---|---|---|---|---|---|---|
| Nu se cunosc tranzacții neplanificate pe piața deschisă pentru această combinație de informații privilegiate și de securitate |
Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.
Istoricul tranzacțiilor privilegiate
Acest tabel arată lista completă a tranzacțiilor privilegiate efectuate de Ernest Mario, astfel cum a fost dezvăluită Comisiei pentru Bursa de Valori Valori (SEC).
| Data fișierului | Tran Data | Formă | Ticker | Securitate | Cod | Acțiuni | Acțiuni rămase | La sută Schimbare |
Acțiune Preț |
Tran Valoare |
Rămas Valoare |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-10 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 6.500 | 193.066 | 3,48 | ||||
| 2024-05-23 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
X - Other | 62.000 | 186.566 | 49,77 | 4,50 | 279.000 | 839.547 | |
| 2024-01-10 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
G - Gift | -3.523 | 124.566 | -2,75 | ||||
| 2023-12-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
G - Gift | -8.700 | 128.089 | -6,36 | ||||
| 2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Warrant (right to buy) |
P - Purchase | 930.000 | 930.000 | |||||
| 2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Warrant (right to buy) |
P - Purchase | 930.000 | 930.000 | |||||
| 2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 930.000 | 930.000 | |||||
| 2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 930.000 | 930.000 | |||||
| 2022-02-02 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 56.338 | 1.433.135 | 4,09 | 0,36 | 20.000 | 508.763 | |
| 2021-11-22 |
|
4 | EYEN |
EYENOVIA, INC.
Stock Option (right to buy) |
A - Award | 9.653 | 9.653 | |||||
| 2021-11-22 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
A - Award | 6.963 | 382.706 | 1,85 | ||||
| 2021-11-02 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 26.888 | 1.376.797 | 1,99 | ||||
| 2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 21.978 | 1.349.909 | 1,66 | 0,91 | 20.000 | 1.228.417 | |
| 2021-06-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 31.862 | 31.862 | |||||
| 2021-05-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 16.529 | 1.176.416 | 1,43 | 1,21 | 20.000 | 1.423.463 | |
| 2021-02-02 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 8.928 | 1.157.804 | 0,78 | ||||
| 2021-01-22 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 49.000 | 49.000 | |||||
| 2021-01-19 |
|
4 | EYEN |
EYENOVIA, INC.
Class A Warrant |
X - Other | -41.216 | 0 | -100,00 | ||||
| 2021-01-19 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
X - Other | 41.216 | 375.743 | 12,32 | 2,27 | 93.560 | 852.937 | |
| 2021-01-12 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 40.000 | 40.000 | |||||
| 2020-11-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 10.057 | 1.148.876 | 0,88 | 1,74 | 17.499 | 1.999.044 | |
| 2020-09-15 |
|
4 | EYEN |
EYENOVIA, INC.
Stock Option (right to buy) |
A - Award | 9.820 | 9.820 | |||||
| 2020-09-15 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
A - Award | 7.288 | 334.527 | 2,23 | ||||
| 2020-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 10.174 | 10.174 | 1,72 | 17.499 | 17.499 | ||
| 2020-05-20 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 9.530 | 9.530 | |||||
| 2020-05-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 5.738 | 5.738 | 3,05 | 17.501 | 17.501 | ||
| 2020-03-26 |
|
4 | EYEN |
EYENOVIA, INC.
Class B Warrant |
P - Purchase | 61.823 | 61.823 | |||||
| 2020-03-26 |
|
4 | EYEN |
EYENOVIA, INC.
Class A Warrant |
P - Purchase | 41.216 | 41.216 | |||||
| 2020-03-26 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
P - Purchase | 82.431 | 327.239 | 33,67 | 2,27 | 187.118 | 742.833 | |
| 2020-01-24 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 10.448 | 10.448 | 3,35 | 35.001 | 35.001 | ||
| 2020-01-22 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 49.000 | 49.000 | |||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -4.756 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -970 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -300 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -13.266 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -10.500 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -11.000 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -10.000 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -20.700 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
D - Sale to Issuer | -4.908 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
D - Sale to Issuer | -62.884 | 0 | -100,00 | ||||
| 2019-08-20 |
|
4 | EYEN |
EYENOVIA, INC.
Stock Option (right to buy) |
A - Award | 9.057 | 9.057 | |||||
| 2019-08-20 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
A - Award | 8.038 | 280.779 | 2,95 | ||||
| 2019-07-15 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
P - Purchase | 35.971 | 272.741 | 15,19 | 2,78 | 99.999 | 758.220 | |
| 2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -375 | 0 | -100,00 | ||||
| 2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 375 | 62.884 | 0,60 | ||||
| 2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -300 | 300 | -50,00 | ||||
| 2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 300 | 62.509 | 0,48 | ||||
| 2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -484 | 970 | -33,29 | ||||
| 2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 484 | 62.209 | 0,78 | ||||
| 2019-06-12 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 13.000 | 13.000 | |||||
| 2019-06-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 4.756 | 4.756 | |||||
| 2019-05-21 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
P - Purchase | 90.000 | 236.770 | 61,32 | 10,00 | 900.000 | 2.367.700 | |
| 2019-03-07 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
J - Other | 2.908 | 4.908 | 145,40 | 85,97 | 250.001 | 421.941 | |
| 2019-03-07 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
J - Other | -2.908 | 55.005 | -5,02 | 85,97 | -250.001 | 4.728.780 | |
| 2019-02-14 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
P - Purchase | 2.000 | 2.000 | 89,99 | 179.980 | 179.980 | ||
| 2019-02-14 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -5.100 | 57.913 | -8,09 | ||||
| 2019-02-05 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 49.000 | 49.000 | |||||
| 2018-12-20 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -8.600 | 0 | -100,00 | ||||
| 2018-12-20 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 8.600 | 63.013 | 15,81 | 59,06 | 507.873 | 3.721.233 | |
| 2018-11-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -10.000 | 8.600 | -53,76 | ||||
| 2018-11-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 10.000 | 54.413 | 22,52 | 59,06 | 590.550 | 3.213.360 | |
| 2018-10-31 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -44.000 | 0 | -100,00 | ||||
| 2018-10-31 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -833 | 0 | -100,00 | ||||
| 2018-10-31 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 44.000 | 169.000 | 35,20 | 3,45 | 151.800 | 583.050 | |
| 2018-10-31 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 833 | 125.000 | 0,67 | 1,37 | 1.141 | 171.250 | |
| 2018-08-13 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -12.000 | 44.413 | -21,27 | 92,32 | -1.107.888 | 4.100.386 | |
| 2018-07-26 |
|
4 | EYEN |
EYENOVIA, INC.
Stock Option (right to buy) |
A - Award | 4.465 | 4.465 | |||||
| 2018-07-26 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
A - Award | 4.033 | 146.770 | 2,83 | ||||
| 2018-06-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 16.500 | 50.000 | 49,25 | 4,48 | 73.920 | 224.000 | |
| 2018-06-26 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (Right to Buy) |
A - Award | 10.000 | 10.000 | |||||
| 2018-06-18 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -334 | 0 | -100,00 | ||||
| 2018-06-18 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 334 | 56.413 | 0,60 | ||||
| 2018-06-18 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 15.931 | 15.931 | |||||
| 2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -375 | 375 | -50,00 | ||||
| 2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 375 | 56.079 | 0,67 | ||||
| 2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -300 | 600 | -33,33 | ||||
| 2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 300 | 55.704 | 0,54 | ||||
| 2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 13.266 | 13.266 | |||||
| 2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 1.454 | 1.454 | |||||
| 2018-06-13 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 20.000 | 20.000 | |||||
| 2018-06-13 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 3.606 | 475.324 | 0,76 | 2,04 | 7.356 | 969.661 | |
| 2018-06-13 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 500 | 471.718 | 0,11 | 2,04 | 1.020 | 962.305 | |
| 2018-06-13 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 4.980 | 471.218 | 1,07 | 2,05 | 10.209 | 965.997 | |
| 2018-06-11 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 14.803 | 466.238 | 3,28 | 2,04 | 30.257 | 952.990 | |
| 2018-06-11 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 4.611 | 451.435 | 1,03 | 2,00 | 9.234 | 903.999 | |
| 2018-06-07 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 1.200 | 446.824 | 0,27 | 2,05 | 2.460 | 915.989 | |
| 2018-06-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 1.300 | 445.624 | 0,29 | 2,05 | 2.665 | 913.529 | |
| 2018-06-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 500 | 444.324 | 0,11 | 2,05 | 1.025 | 910.864 | |
| 2018-05-29 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 500 | 443.824 | 0,11 | 2,01 | 1.005 | 892.086 | |
| 2018-05-29 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 5.000 | 443.324 | 1,14 | 2,05 | 10.250 | 908.814 | |
| 2018-05-22 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 5.000 | 438.324 | 1,15 | 1,94 | 9.720 | 852.102 | |
| 2018-05-22 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 25.000 | 433.324 | 6,12 | 1,95 | 48.750 | 844.982 | |
| 2018-05-21 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -15.000 | 108.167 | -12,18 | 4,81 | -72.142 | 520.229 | |
| 2018-05-21 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -30.000 | 123.167 | -19,59 | 4,80 | -143.931 | 590.918 | |
| 2018-05-21 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 25.000 | 408.324 | 6,52 | 1,90 | 47.500 | 775.816 | |
| 2018-05-17 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -30.000 | 153.167 | -16,38 | 4,79 | -143.808 | 734.221 | |
| 2018-05-16 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -30.000 | 183.167 | -14,07 | 4,69 | -140.808 | 859.713 | |
| 2018-05-15 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -22.553 | 213.167 | -9,57 | 4,67 | -105.232 | 994.637 | |
| 2018-05-15 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -22.857 | 235.720 | -8,84 | 4,63 | -105.766 | 1.090.747 | |
| 2018-05-15 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -7.143 | 258.577 | -2,69 | 4,57 | -32.614 | 1.180.637 | |
| 2018-05-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -2.815 | 265.720 | -1,05 | 4,60 | -12.949 | 1.222.312 | |
| 2018-04-24 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (Right to Buy) |
A - Award | 44.603 | 44.603 | |||||
| 2018-04-11 | 3 | KIN |
Kindred Biosciences, Inc.
Common Stock |
248.334 | ||||||||
| 2018-04-11 | 3 | KIN |
Kindred Biosciences, Inc.
Common Stock |
248.334 | ||||||||
| 2018-04-11 | 3 | KIN |
Kindred Biosciences, Inc.
Common Stock |
248.334 | ||||||||
| 2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
G - Gift | 10.000 | 33.500 | 42,55 | ||||
| 2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
G - Gift | -10.000 | 0 | -100,00 | ||||
| 2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Units |
M - Exercise | -750 | 0 | -100,00 | ||||
| 2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
M - Exercise | 750 | 64.572 | 1,18 | ||||
| 2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Units |
M - Exercise | -750 | 0 | -100,00 | ||||
| 2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
M - Exercise | 750 | 63.822 | 1,19 | ||||
| 2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Units |
M - Exercise | -600 | 0 | -100,00 | ||||
| 2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
M - Exercise | 600 | 26.648 | 2,30 | ||||
| 2018-02-26 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -13.370 | 55.404 | -19,44 | 94,49 | -1.263.298 | 5.234.985 | |
| 2018-02-26 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -2.250 | 324 | -87,41 | ||||
| 2018-02-26 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -2.250 | 324 | -87,41 | ||||
| 2018-02-07 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 8.689 | 704.352 | 1,25 | 1,73 | 15.000 | 1.215.923 | |
| 2018-01-24 | 3 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
285.474 | ||||||||
| 2018-01-24 | 3 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
285.474 | ||||||||
| 2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -5.000 | 23.500 | -17,54 | 3,46 | -17.300 | 81.310 | |
| 2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -8.965 | 28.500 | -23,93 | 3,44 | -30.840 | 98.040 | |
| 2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -6.035 | 37.465 | -13,87 | 3,51 | -21.183 | 131.502 | |
| 2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -10.000 | 43.500 | -18,69 | 3,57 | -35.700 | 155.295 | |
| 2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -5.000 | 53.500 | -8,55 | 3,55 | -17.750 | 189.925 | |
| 2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -1.967 | 55.467 | -3,42 | 3,58 | -7.042 | 198.572 | |
| 2017-11-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -13.600 | 0 | -100,00 | ||||
| 2017-11-01 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 13.600 | 71.024 | 23,68 | 31,80 | 432.412 | 2.258.208 | |
| 2017-10-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 28.846 | 1.873.174 | 1,56 | 0,52 | 15.000 | 974.050 | |
| 2017-08-31 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -12.000 | 57.424 | -17,29 | 121,24 | -1.454.880 | 6.962.086 | |
| 2017-08-14 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -18.506 | 69.424 | -21,05 | 130,52 | -2.415.403 | 9.061.220 | |
| 2017-07-17 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 24.590 | 1.844.328 | 1,35 | 0,61 | 15.000 | 1.125.040 | |
| 2017-07-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -734 | 0 | -100,00 | ||||
| 2017-07-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 734 | 87.930 | 0,84 | ||||
| 2017-06-30 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -6.105 | 5.895 | -50,88 | 4,28 | -26.117 | 25.219 | |
| 2017-06-29 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 6.341 | 6.341 | |||||
| 2017-06-29 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 21.000 | 21.000 | |||||
| 2017-06-21 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 20.000 | 20.000 | |||||
| 2017-06-20 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -333 | 334 | -49,93 | ||||
| 2017-06-20 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 333 | 87.196 | 0,38 | ||||
| 2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -375 | 750 | -33,33 | ||||
| 2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 375 | 86.863 | 0,43 | ||||
| 2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 900 | 900 | |||||
| 2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 10.500 | 10.500 | |||||
| 2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -3.570 | 86.488 | -3,96 | ||||
| 2017-05-09 |
|
4 | CAPN |
Capnia, Inc.
Employee stock option (right to buy) |
A - Award | 45.139 | 45.139 | |||||
| 2017-04-13 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
A - Award | 23.809 | 1.819.738 | 1,33 | 0,63 | 15.000 | 1.146.435 | |
| 2017-04-13 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
A - Award | 16.667 | 1.795.929 | 0,94 | 0,90 | 15.000 | 1.616.336 | |
| 2017-01-31 |
|
5 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -4.125 | 90.058 | -4,38 | ||||
| 2016-12-29 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -20.291 | 268.535 | -7,03 | 4,52 | -91.634 | 1.212.704 | |
| 2016-12-29 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -4.000 | 288.826 | -1,37 | 4,67 | -18.683 | 1.349.020 | |
| 2016-12-29 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -3.636 | 292.826 | -1,23 | 4,65 | -16.907 | 1.361.641 | |
| 2016-12-29 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | X | -72.073 | 296.462 | -19,56 | 4,68 | -337.143 | 1.386.790 |
| 2016-11-28 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 120.000 | 120.000 | 0,40 | 48.600 | 48.600 | ||
| 2016-10-31 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock Purchase Warrant |
P - Purchase | 100.000 | 100.000 | |||||
| 2016-10-31 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 100.000 | 630.724 | 18,84 | ||||
| 2016-10-11 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
A - Award | 15.625 | 1.779.262 | 0,89 | ||||
| 2016-09-26 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -15.000 | 90.058 | -14,28 | 109,42 | -1.641.300 | 9.854.146 | |
| 2016-09-14 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 100.000 | 530.724 | 23,22 | 0,79 | 79.180 | 420.227 | |
| 2016-08-19 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 25.000 | 1.763.637 | 1,44 | 0,99 | 24.750 | 1.746.001 | |
| 2016-08-19 |
|
4/A | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 5.637 | 1.688.637 | 0,33 | 1,20 | 6.764 | 2.026.364 | |
| 2016-08-19 |
|
4/A | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 43.169 | 1.683.000 | 2,63 | 1,18 | 50.875 | 1.983.416 | |
| 2016-08-19 |
|
4/A | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 50.000 | 1.738.637 | 2,96 | 1,24 | 62.000 | 2.155.910 | |
| 2016-07-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -733 | 734 | -49,97 | ||||
| 2016-07-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 733 | 105.058 | 0,70 | ||||
| 2016-06-28 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 9.634 | 9.634 | |||||
| 2016-06-28 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 9.000 | 9.000 | |||||
| 2016-06-28 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 50.000 | 381.440 | 15,09 | 3,70 | 184.845 | 1.410.146 | |
| 2016-06-21 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 50.000 | 430.724 | 13,13 | 2,00 | 100.000 | 861.448 | |
| 2016-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -333 | 667 | -33,30 | ||||
| 2016-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 333 | 104.325 | 0,32 | ||||
| 2016-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 1.125 | 1.125 | |||||
| 2016-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 11.000 | 11.000 | |||||
| 2016-06-13 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -2.068 | 0 | -100,00 | ||||
| 2016-06-13 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2.068 | 103.992 | 2,03 | ||||
| 2016-06-10 |
|
4 | CAPN |
Capnia, Inc.
Employee stock option (right to buy) |
A - Award | 27.083 | 27.083 | |||||
| 2016-06-09 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 50.000 | 1.918.637 | 2,68 | 1,24 | 62.000 | 2.379.110 | |
| 2016-05-31 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Unit |
A - Award | 7.500 | 7.500 | |||||
| 2016-05-23 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 5.637 | 1.868.637 | 0,30 | 1,20 | 6.764 | 2.242.364 | |
| 2016-05-23 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 43.169 | 1.863.000 | 2,37 | 1,18 | 50.875 | 2.195.546 | |
| 2016-05-16 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 10.000 | 331.440 | 3,11 | 4,53 | 45.328 | 1.502.351 | |
| 2016-05-12 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 31.042 | 380.724 | 8,88 | 2,30 | 71.356 | 875.170 | |
| 2016-05-11 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 8.210 | 349.682 | 2,40 | 2,24 | 18.399 | 783.672 | |
| 2016-05-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 24.200 | 321.440 | 8,14 | 4,85 | 117.365 | 1.558.920 | |
| 2016-05-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 800 | 297.240 | 0,27 | 4,76 | 3.804 | 1.413.376 | |
| 2016-05-05 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.761 | 15.845 | -10,00 | ||||
| 2016-05-05 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.761 | 296.440 | 0,60 | 5,05 | 8.893 | 1.497.022 | |
| 2016-04-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -5.000 | 13.600 | -26,88 | ||||
| 2016-04-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5.000 | 101.924 | 5,16 | 31,80 | 158.975 | 3.240.674 | |
| 2016-04-05 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.760 | 17.606 | -9,09 | ||||
| 2016-04-05 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.760 | 294.679 | 0,60 | 5,05 | 8.888 | 1.488.129 | |
| 2016-03-17 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
P - Purchase | 30.000 | 99.583 | 43,11 | 3,55 | 106.500 | 353.520 | |
| 2016-03-17 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 75.000 | 341.472 | 28,15 | 2,29 | 171.712 | 781.800 | |
| 2016-03-16 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 5.000 | 292.919 | 1,74 | 4,78 | 23.898 | 1.400.036 | |
| 2016-03-16 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 20.000 | 287.919 | 7,46 | 5,13 | 102.628 | 1.477.428 | |
| 2016-03-09 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.761 | 19.366 | -8,34 | ||||
| 2016-03-09 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.761 | 267.919 | 0,66 | 5,05 | 8.893 | 1.352.991 | |
| 2016-02-10 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Unit |
A - Award | 7.500 | 7.500 | |||||
| 2016-02-09 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.760 | 21.127 | -7,69 | ||||
| 2016-02-09 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.760 | 266.158 | 0,67 | 5,05 | 8.888 | 1.344.098 | |
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -18.600 | 0 | -100,00 | ||||
| 2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 18.600 | 101.049 | 22,56 | 29,00 | 539.400 | 2.930.421 | |
| 2016-01-14 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.761 | 22.887 | -7,14 | ||||
| 2016-01-14 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.761 | 264.398 | 0,67 | 5,05 | 8.893 | 1.335.210 | |
| 2016-01-12 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 44.000 | 44.000 | |||||
| 2015-12-30 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 125.000 | 262.637 | 90,82 | 7,09 | 886.612 | 1.862.858 | |
| 2015-12-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -40.000 | 82.449 | -32,67 | 119,36 | -4.774.400 | 9.841.113 | |
| 2015-12-11 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.760 | 24.648 | -6,66 | ||||
| 2015-12-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.760 | 137.637 | 1,30 | 5,05 | 8.888 | 695.067 | |
| 2015-11-18 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 50.000 | 1.639.831 | 3,14 | 1,77 | 88.500 | 2.902.501 | |
| 2015-11-17 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -125.000 | 86.032 | -59,23 | 17,63 | -2.203.162 | 1.516.340 | |
| 2015-11-10 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.761 | 26.408 | -6,25 | ||||
| 2015-11-10 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.761 | 135.877 | 1,31 | 5,05 | 8.893 | 686.179 | |
| 2015-10-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.761 | 28.169 | -5,88 | ||||
| 2015-10-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.761 | 134.116 | 1,33 | 5,05 | 8.893 | 677.286 | |
| 2015-09-14 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 15.000 | 1.589.831 | 0,95 | 2,28 | 34.200 | 3.624.815 | |
| 2015-09-08 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -832 | 8.319 | -9,09 | ||||
| 2015-09-08 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.760 | 29.930 | -5,55 | ||||
| 2015-09-08 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 832 | 132.355 | 0,63 | 45,15 | 37.565 | 5.975.828 | |
| 2015-09-08 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.760 | 131.523 | 1,36 | 5,05 | 8.888 | 664.191 | |
| 2015-08-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 10.000 | 260.472 | 3,99 | 6,05 | 60.500 | 1.575.856 | |
| 2015-08-26 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 1.468 | 250.472 | 0,59 | 6,40 | 9.395 | 1.603.021 | |
| 2015-08-25 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 16.228 | 1.553.999 | 1,06 | 1,91 | 30.995 | 2.968.138 | |
| 2015-08-25 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 2.532 | 249.004 | 1,03 | 6,20 | 15.698 | 1.543.825 | |
| 2015-08-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant (right to buy) |
J - Other | -50.000 | 0 | -100,00 | ||||
| 2015-08-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
J - Other | 210.251 | 1.477.771 | 16,59 | ||||
| 2015-08-20 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 6.000 | 246.472 | 2,50 | 6,64 | 39.867 | 1.637.683 | |
| 2015-08-20 |
|
4/A | CAPN |
Capnia, Inc.
Common Stock |
J - Other | 210.251 | 1.537.771 | 15,84 | ||||
| 2015-08-17 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 15.000 | 240.472 | 6,65 | 6,93 | 104.018 | 1.667.553 | |
| 2015-08-13 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 10.000 | 1.327.520 | 0,76 | 1,64 | 16.440 | 2.182.443 | |
| 2015-08-12 |
|
4 | CAPN |
Capnia, Inc.
Warrant (right to buy) |
J - Other | -205.188 | 0 | -100,00 | ||||
| 2015-08-12 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 50.000 | 1.317.520 | 3,94 | 1,77 | 88.500 | 2.332.010 | |
| 2015-08-12 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
J - Other | 786.645 | 1.267.520 | 163,59 | ||||
| 2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -832 | 9.151 | -8,33 | ||||
| 2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -129 | 0 | -100,00 | ||||
| 2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -750 | 0 | -100,00 | ||||
| 2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3.521 | 31.690 | -10,00 | ||||
| 2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 832 | 129.763 | 0,65 | 45,15 | 37.565 | 5.858.799 | |
| 2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 129 | 128.931 | 0,10 | 23,26 | 3.001 | 2.998.935 | |
| 2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 750 | 128.802 | 0,59 | 23,26 | 17.445 | 2.995.935 | |
| 2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3.521 | 128.052 | 2,83 | 5,05 | 17.781 | 646.663 | |
| 2015-08-04 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -19.442 | 122.449 | -13,70 | 131,73 | -2.561.139 | 16.130.488 | |
| 2015-07-17 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 25.000 | 225.472 | 12,47 | 7,50 | 187.500 | 1.691.040 | |
| 2015-07-06 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -733 | 1.467 | -33,32 | ||||
| 2015-07-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 733 | 141.891 | 0,52 | ||||
| 2015-06-26 |
|
4 | CAPN |
Capnia, Inc.
Employee stock option (right to buy) |
M - Exercise | -54.999 | 0 | -100,00 | ||||
| 2015-06-26 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
M - Exercise | 54.999 | 480.875 | 12,91 | 3,48 | 191.397 | 1.673.445 | |
| 2015-06-24 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 9.983 | 9.983 | |||||
| 2015-06-19 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 1.000 | 1.000 | |||||
| 2015-06-19 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 10.000 | 10.000 | |||||
| 2015-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -2.068 | 0 | -100,00 | ||||
| 2015-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2.068 | 141.158 | 1,49 | ||||
| 2015-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -2.066 | 2.068 | -49,98 | ||||
| 2015-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2.066 | 139.090 | 1,51 | ||||
| 2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -258 | 129 | -66,67 | ||||
| 2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.500 | 750 | -66,67 | ||||
| 2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3.521 | 35.211 | -9,09 | ||||
| 2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 258 | 124.531 | 0,21 | 23,26 | 6.001 | 2.896.591 | |
| 2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.500 | 124.273 | 1,22 | 23,26 | 34.890 | 2.890.590 | |
| 2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3.521 | 122.773 | 2,95 | 5,05 | 17.781 | 620.004 | |
| 2015-06-08 |
|
4 | CAPN |
Capnia, Inc.
Employee stock option (right to buy) |
M - Exercise | -25.000 | 54.999 | -31,25 | ||||
| 2015-06-08 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
M - Exercise | 25.000 | 425.876 | 6,24 | 3,48 | 87.000 | 1.482.048 | |
| 2015-06-04 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | 8.750 | 11.250 | 350,00 | ||||
| 2015-06-04 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | 8.333 | 14.167 | 142,84 | ||||
| 2015-06-04 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 8.750 | 69.583 | 14,38 | 1,37 | 11.988 | 95.329 | |
| 2015-06-04 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common STock |
M - Exercise | 8.333 | 60.833 | 15,87 | 0,32 | 2.667 | 19.467 | |
| 2015-05-21 |
|
4 | XNPT |
XENOPORT INC
Non-Employee Restricted Stock Unit |
M - Exercise | -5.000 | 0 | -100,00 | ||||
| 2015-05-21 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
M - Exercise | 5.000 | 88.750 | 5,97 | ||||
| 2015-05-19 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -50.000 | 211.032 | -19,15 | 18,09 | -904.630 | 3.818.118 | |
| 2015-05-19 |
|
4 | CAPN |
Capnia, Inc.
Employee Stock Option |
A - Award | 5.000 | 5.000 | |||||
| 2015-05-07 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Deferred Stock Units |
A - Award | 10.650 | 10.650 | |||||
| 2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -130 | 387 | -25,15 | ||||
| 2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -750 | 2.250 | -25,00 | ||||
| 2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.761 | 38.732 | -4,35 | ||||
| 2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 130 | 119.252 | 0,11 | 23,26 | 3.024 | 2.773.802 | |
| 2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 750 | 119.122 | 0,63 | 23,26 | 17.445 | 2.770.778 | |
| 2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.761 | 118.372 | 1,51 | 5,05 | 8.893 | 597.779 | |
| 2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -258 | 517 | -33,29 | ||||
| 2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.500 | 3.000 | -33,33 | ||||
| 2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3.521 | 40.493 | -8,00 | ||||
| 2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 258 | 116.611 | 0,22 | 23,26 | 6.001 | 2.712.372 | |
| 2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.500 | 116.353 | 1,31 | 23,26 | 34.890 | 2.706.371 | |
| 2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3.521 | 114.853 | 3,16 | 5,05 | 17.781 | 580.008 | |
| 2015-03-06 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 4.000 | 200.472 | 2,04 | 6,57 | 26.280 | 1.317.081 | |
| 2015-02-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Unit |
A - Award | 6.000 | 6.000 | |||||
| 2015-02-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 5.000 | 5.000 | |||||
| 2015-02-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 30.000 | 196.472 | 18,02 | 5,85 | 175.500 | 1.149.361 | |
| 2015-02-04 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -7.666 | 0 | -100,00 | ||||
| 2015-02-04 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 7.666 | 137.024 | 5,93 | 27,69 | 212.272 | 3.794.195 | |
| 2015-01-28 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 44.000 | 44.000 | |||||
| 2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock (Right to Buy) |
M - Exercise | -258 | 775 | -24,98 | ||||
| 2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.500 | 4.500 | -25,00 | ||||
| 2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3.521 | 44.014 | -7,41 | ||||
| 2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 258 | 111.332 | 0,23 | 23,26 | 6.001 | 2.589.582 | |
| 2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.500 | 111.074 | 1,37 | 23,26 | 34.890 | 2.583.581 | |
| 2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3.521 | 109.574 | 3,32 | 5,05 | 17.781 | 553.349 | |
| 2015-01-13 |
|
4 | CAPN |
Capnia, Inc.
Employee Stock Option |
A - Award | 5.000 | 5.000 | |||||
| 2014-12-19 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Series A common stock purchase warrant |
X - Other | -30.000 | 0 | -100,00 | ||||
| 2014-12-19 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
X - Other | 30.000 | 166.472 | 21,98 | 4,25 | 127.500 | 707.506 | |
| 2014-12-02 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 261.032 | -3,69 | 12,96 | -129.618 | 3.383.445 |
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series A Warrant to Purchase Common Stock |
P - Purchase | 253.846 | 597.232 | 73,92 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series B Warrant to Purchase Common Stock |
P - Purchase | 253.846 | 597.232 | 73,92 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series A Warrant to Purchase Common Stock |
P - Purchase | 44.770 | 89.540 | 100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series B Warrant to Purchase Common Stock |
P - Purchase | 44.770 | 89.540 | 100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant to Purchase Common Stock |
J - Other | 21.928 | 43.893 | 99,83 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant to Purchase Common Stock |
J - Other | 8.275 | 21.965 | 60,45 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant to Purchase Common Stock |
J - Other | 13.690 | 13.690 | |||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series C Preferred Stock |
C - Conversion | -10.416 | 0 | -100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series C Preferred Stock |
C - Conversion | -10.416 | 0 | -100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series C Preferred Stock |
C - Conversion | -48.885 | 20.832 | -70,12 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2014 Convertible Promissory Notes |
S - Sale | -203.705 | 0 | -100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2010/2012 Convertible Promissory Notes |
S - Sale | -555.250 | 0 | -100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2010/2012 Convertible Promissory Notes |
S - Sale | -260.471 | 0 | -100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2010/2012 Convertible Promissory Notes |
S - Sale | -471.192 | 0 | -100,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 253.846 | 632.720 | 67,00 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 44.770 | 378.874 | 13,40 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 114.072 | 334.104 | 51,84 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 53.512 | 220.032 | 32,14 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 96.803 | 166.520 | 138,85 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 10.416 | 69.717 | 17,56 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 10.416 | 69.717 | 17,56 | ||||
| 2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 48.885 | 48.885 | |||||
| 2014-11-14 |
|
4 | CAPN |
Capnia, Inc.
Employee Stock Option |
A - Award | 7.000 | 56.772 | 14,06 | ||||
| 2014-11-14 |
|
4 | CAPN |
Capnia, Inc.
Employee Stock Option |
A - Award | 49.772 | 56.772 | 711,03 | ||||
| 2014-11-12 | 3 | CAPN |
Capnia, Inc.
No securities beneficially owned |
0 | ||||||||
| 2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 10.000 | 106.053 | 10,41 | 29,00 | 290.000 | 3.075.537 | |
| 2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -517 | 1.033 | -33,35 | ||||
| 2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3.000 | 6.000 | -33,33 | ||||
| 2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -5.282 | 47.535 | -10,00 | ||||
| 2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 517 | 96.053 | 0,54 | 23,26 | 12.025 | 2.234.193 | |
| 2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3.000 | 95.536 | 3,24 | 23,26 | 69.780 | 2.222.167 | |
| 2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 5.282 | 92.536 | 6,05 | 5,05 | 26.674 | 467.307 | |
| 2014-11-04 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 271.032 | -3,56 | 13,30 | -132.998 | 3.604.671 |
| 2014-11-03 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
A - Award | 13.177 | 281.032 | 4,92 | ||||
| 2014-10-31 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 5.000 | 5.000 | |||||
| 2014-10-29 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -100.000 | 129.358 | -43,60 | 102,85 | -10.284.630 | 13.303.992 | |
| 2014-10-09 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 267.855 | -3,60 | 12,06 | -120.600 | 3.230.331 |
| 2014-09-29 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Series A common stock purchase warrant |
X - Other | -10.000 | 30.000 | -25,00 | ||||
| 2014-09-29 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
X - Other | 10.000 | 136.472 | 7,91 | 4,25 | 42.500 | 580.006 | |
| 2014-09-08 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 10.000 | 87.254 | 12,94 | 23,19 | 231.872 | 2.023.176 | |
| 2014-09-03 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 277.855 | -3,47 | 12,60 | -125.992 | 3.500.751 |
| 2014-09-03 |
|
4 | Kin |
Kindred Biosciences, Inc.
Common Stock |
P - Purchase | 10.000 | 52.500 | 23,53 | 10,55 | 105.493 | 553.838 | |
| 2014-08-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Series A common stock purchase warrant |
X - Other | -7.059 | 40.000 | -15,00 | ||||
| 2014-08-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
X - Other | 7.059 | 126.472 | 5,91 | 4,25 | 30.001 | 537.506 | |
| 2014-08-27 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -8.803 | 52.817 | -14,29 | ||||
| 2014-08-27 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 8.803 | 77.254 | 12,86 | 5,05 | 44.455 | 390.133 | |
| 2014-08-06 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -2.500 | 22.500 | -10,00 | ||||
| 2014-08-06 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 2.500 | 42.500 | 6,25 | 0,32 | 800 | 13.600 | |
| 2014-08-05 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 287.855 | -3,36 | 12,58 | -125.817 | 3.621.705 |
| 2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -5.000 | 7.666 | -39,48 | ||||
| 2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5.000 | 229.358 | 2,23 | 27,69 | 138.450 | 6.350.923 | |
| 2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -196 | 2.574 | -7,08 | ||||
| 2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -196 | 2.574 | -7,08 | ||||
| 2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -2.210 | 2.770 | -44,38 | ||||
| 2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -2.210 | 2.770 | -44,38 | ||||
| 2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -1.020 | 4.980 | -17,00 | ||||
| 2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -1.020 | 4.980 | -17,00 | ||||
| 2014-07-02 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 297.855 | -3,25 | 12,95 | -129.468 | 3.856.269 |
| 2014-07-02 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 2.200 | 2.200 | |||||
| 2014-07-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 20.700 | 20.700 | |||||
| 2014-06-24 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 1.550 | 1.550 | |||||
| 2014-06-24 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 9.000 | 9.000 | |||||
| 2014-06-19 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 5.000 | 5.000 | |||||
| 2014-06-17 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock unit |
A - Award | 5.000 | 5.000 | |||||
| 2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2.055 | 113.892 | 1,84 | ||||
| 2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -2.055 | 0 | -100,00 | ||||
| 2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -3.100 | 0 | -100,00 | ||||
| 2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3.100 | 111.837 | 2,85 | ||||
| 2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -1.033 | 1.034 | -49,98 | ||||
| 2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1.033 | 108.737 | 0,96 | ||||
| 2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -1.033 | 2.067 | -33,32 | ||||
| 2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1.033 | 107.704 | 0,97 | ||||
| 2014-06-11 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock option |
A - Award | 15.000 | 15.000 | |||||
| 2014-06-03 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 307.855 | -3,15 | 12,88 | -128.790 | 3.964.865 |
| 2014-05-28 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 10.000 | 68.451 | 17,11 | 14,22 | 142.200 | 973.373 | |
| 2014-05-27 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
P - Purchase | 30.000 | 83.750 | 55,81 | 3,73 | 111.978 | 312.605 | |
| 2014-05-23 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -2.500 | 25.000 | -9,09 | ||||
| 2014-05-23 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 2.500 | 40.000 | 6,67 | 0,32 | 800 | 12.800 | |
| 2014-05-16 |
|
4 | XNPT |
XENOPORT INC
Non-employee direct stock unit |
M - Exercise | -5.000 | 0 | -100,00 | ||||
| 2014-05-16 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
M - Exercise | 5.000 | 53.750 | 10,26 | ||||
| 2014-05-02 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 317.855 | -3,05 | 12,58 | -125.836 | 3.999.760 |
| 2014-04-08 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -6.000 | 6.333 | -48,65 | ||||
| 2014-04-08 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6.000 | 106.671 | 5,96 | 55,38 | 332.280 | 5.907.440 | |
| 2014-04-02 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 327.855 | -2,96 | 13,55 | -135.527 | 4.443.320 |
| 2014-04-01 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -7.047 | 61.620 | -10,26 | ||||
| 2014-04-01 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 7.047 | 58.451 | 13,71 | 5,05 | 35.587 | 295.178 | |
| 2014-03-05 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 337.855 | -2,87 | 12,98 | -129.755 | 4.383.838 |
| 2014-02-26 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 5.500 | 5.500 | |||||
| 2014-02-07 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -17.104 | 347.855 | -4,69 | 12,80 | -218.935 | 4.452.614 | |
| 2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -6.875 | 0 | -100,00 | ||||
| 2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4.625 | 0 | -100,00 | ||||
| 2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2.000 | 0 | -100,00 | ||||
| 2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -13.500 | 100.671 | -11,82 | 151,87 | -2.050.284 | 15.289.197 | |
| 2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6.875 | 114.171 | 6,41 | 60,02 | 412.638 | 6.852.543 | |
| 2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4.625 | 107.296 | 4,50 | 67,75 | 313.344 | 7.269.304 | |
| 2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2.000 | 102.671 | 1,99 | 59,89 | 119.780 | 6.148.966 | |
| 2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -7.000 | 6.875 | -50,45 | ||||
| 2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 7.000 | 100.671 | 7,47 | 60,02 | 420.140 | 6.042.273 | |
| 2014-02-05 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -12.500 | 27.500 | -31,25 | ||||
| 2014-02-05 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 12.500 | 37.500 | 50,00 | 0,32 | 4.000 | 12.000 | |
| 2014-02-05 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 37.000 | 37.000 | |||||
| 2014-02-04 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 364.959 | -2,67 | 13,19 | -131.884 | 4.813.225 |
| 2014-01-09 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2.000 | 2.000 | -50,00 | ||||
| 2014-01-09 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2.000 | 93.671 | 2,18 | 59,89 | 119.780 | 5.609.956 | |
| 2014-01-08 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 374.959 | -2,60 | 12,50 | -125.000 | 4.686.988 |
| 2013-12-30 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 384.959 | -2,53 | 12,06 | -120.600 | 4.642.606 |
| 2013-12-13 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
P - Purchase | 25.000 | 25.000 | 7,00 | 175.000 | 175.000 | ||
| 2013-12-13 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 5.000 | 51.404 | 10,77 | 13,90 | 69.500 | 714.516 | |
| 2013-11-25 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 8.000 | 46.404 | 20,83 | 15,20 | 121.600 | 705.341 | |
| 2013-11-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -15.840 | 68.667 | -18,74 | ||||
| 2013-11-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 15.840 | 38.404 | 70,20 | 5,05 | 79.992 | 193.940 | |
| 2013-11-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 7.500 | 22.564 | 49,79 | 15,25 | 114.375 | 344.101 | |
| 2013-11-12 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -20.445 | 0 | -100,00 | 11,73 | -239.857 | ||
| 2013-11-12 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -115.200 | 394.959 | -22,58 | 11,73 | -1.351.503 | 4.633.580 | |
| 2013-10-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -6.000 | 4.000 | -60,00 | ||||
| 2013-10-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6.000 | 91.671 | 7,00 | 59,89 | 359.340 | 5.490.176 | |
| 2013-09-30 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock option |
M - Exercise | -18.750 | 11.250 | -62,50 | ||||
| 2013-09-30 |
|
4 | XNPT |
XENOPORT INC
Common stock |
M - Exercise | 18.750 | 48.750 | 62,50 | 5,79 | 108.562 | 282.262 | |
| 2013-09-03 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 64 | 15.064 | 0,43 | 15,75 | 1.008 | 237.258 | |
| 2013-09-03 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 786 | 15.000 | 5,53 | 15,80 | 12.419 | 237.000 | |
| 2013-09-03 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 1.714 | 14.214 | 13,71 | 15,80 | 27.081 | 224.581 | |
| 2013-09-03 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2.500 | 12.500 | 25,00 | 15,85 | 39.625 | 198.125 | |
| 2013-08-27 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2.000 | 10.000 | 25,00 | 16,80 | 33.600 | 168.000 | |
| 2013-08-27 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2.000 | 8.000 | 33,33 | 17,30 | 34.600 | 138.400 | |
| 2013-08-27 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 1.960 | 6.000 | 48,51 | 17,50 | 34.300 | 105.000 | |
| 2013-08-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 40 | 4.040 | 1,00 | 17,50 | 700 | 70.700 | |
| 2013-08-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2.000 | 4.000 | 100,00 | 17,50 | 35.000 | 70.000 | |
| 2013-08-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2.000 | 2.000 | 17,45 | 34.900 | 34.900 | ||
| 2013-08-15 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4.625 | 0 | -100,00 | ||||
| 2013-08-15 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4.625 | 85.671 | 5,71 | 54,35 | 251.369 | 4.656.219 | |
| 2013-08-15 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Series A common stock purchase warrant |
P - Purchase | 47.059 | 47.059 | |||||
| 2013-08-15 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 47.059 | 119.713 | 64,77 | ||||
| 2013-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -1.033 | 2.067 | -33,32 | ||||
| 2013-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1.033 | 81.046 | 1,29 | ||||
| 2013-06-14 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 3.100 | 3.100 | |||||
| 2013-06-14 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 9.300 | 9.300 | |||||
| 2013-06-07 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -15.000 | 10.000 | -60,00 | ||||
| 2013-06-07 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 15.000 | 80.013 | 23,07 | 59,89 | 898.350 | 4.791.979 | |
| 2013-05-30 |
|
4 | VVUS |
VIVUS INC
Common Stock |
P - Purchase | 15.000 | 81.125 | 22,68 | 14,68 | 220.206 | 1.190.947 | |
| 2013-05-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
P - Purchase | 400 | 65.013 | 0,62 | 123,73 | 49.493 | 8.044.189 | |
| 2013-05-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
P - Purchase | 600 | 64.613 | 0,94 | 123,72 | 74.232 | 7.993.920 | |
| 2013-05-23 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
P - Purchase | 20.000 | 30.000 | 200,00 | 5,49 | 109.800 | 164.700 | |
| 2013-05-16 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock unit |
A - Award | 5.000 | 5.000 | |||||
| 2013-05-16 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock option |
A - Award | 15.000 | 15.000 | |||||
| 2013-05-08 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Phantom Stock |
A - Award | 22.756 | 130.098 | 21,20 | ||||
| 2013-05-08 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 30.000 | 509.304 | 6,26 | 7,76 | 232.800 | 3.952.199 | |
| 2013-04-29 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Warrants |
C - Conversion | -166.667 | 216.667 | -43,48 | ||||
| 2013-04-29 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock |
C - Conversion | 166.667 | 1.447.079 | 13,02 | 0,40 | 66.667 | 578.832 | |
| 2013-02-19 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 210.000 | 0 | -100,00 | ||||
| 2013-01-29 |
|
4 | VVUS |
VIVUS INC
Common Stock |
A - Award | 21.125 | 66.125 | 46,94 | ||||
| 2013-01-14 | 3 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, Par Value $0.001 |
1.280.412 | ||||||||
| 2012-08-21 |
|
4 | VVUS |
VIVUS INC
Common Stock |
P - Purchase | 5.000 | 45.000 | 12,50 | 20,75 | 103.750 | 933.750 | |
| 2012-08-13 |
|
4 | VVUS |
VIVUS INC
Common Stock |
P - Purchase | 5.000 | 40.000 | 14,29 | 21,50 | 107.500 | 860.000 | |
| 2012-08-13 |
|
4 | VVUS |
VIVUS INC
Common Stock |
P - Purchase | 15.000 | 35.000 | 75,00 | 21,83 | 327.399 | 763.931 | |
| 2012-08-09 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
P - Purchase | 10.000 | 10.000 | 8,50 | 84.983 | 84.983 | ||
| 2012-08-08 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 32.000 | 479.304 | 7,15 | 5,29 | 169.280 | 2.535.518 | |
| 2012-06-19 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -685 | 0 | -100,00 | ||||
| 2012-06-19 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 685 | 64.013 | 1,08 | ||||
| 2012-06-18 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock option |
A - Award | 30.000 | 30.000 | |||||
| 2012-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 3.100 | 3.100 | |||||
| 2012-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 9.300 | 9.300 | |||||
| 2012-06-07 |
|
4 | MAXY |
MAXYGEN INC
Common Stock |
A - Award | 10.000 | 62.964 | 18,88 | ||||
| 2012-05-10 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Phantom Stock |
A - Award | 24.116 | 107.342 | 28,98 | ||||
| 2012-04-30 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -12.333 | 0 | -100,00 | ||||
| 2012-04-30 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4.625 | 0 | -100,00 | ||||
| 2012-04-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 12.333 | 63.328 | 24,18 | 44,94 | 554.245 | 2.845.960 | |
| 2012-04-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4.625 | 50.995 | 9,97 | 49,93 | 230.926 | 2.546.180 | |
| 2012-04-27 |
|
4 | VVUS |
VIVUS INC
Common Stock |
A - Award | 20.000 | 20.000 | |||||
| 2012-02-27 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 10.000 | 447.304 | 2,29 | 5,91 | 59.100 | 2.643.567 | |
| 2012-02-23 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 10.000 | 437.304 | 2,34 | 5,93 | 59.300 | 2.593.213 | |
| 2012-02-22 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 20.000 | 427.304 | 4,91 | 6,12 | 122.400 | 2.615.100 | |
| 2011-02-09 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 50.000 | 131.004 | 61,73 | 6,94 | 346.990 | 909.142 | |
| 2009-05-07 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Phantom Stock |
A - Award | 14.501 | 42.521 | 51,75 | ||||
| 2007-08-23 | 3 | CELG |
CELGENE CORP /DE/
Common Stock |
10.000 |
